Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Early estimates of nirsevimab immunoprophylaxis effectiveness against hospital admission for respiratory syncytial virus lower respiratory tract infections in infants, Spain, October 2023 to January 2024.

Autor: López-Lacort M; Vaccine Research Department, Fisabio-Public Health, Valencia, Spain.; These authors contributed equally to this article and share first authorship.; CIBERESP, Instituto de Salud Carlos III, Madrid, Spain., Muñoz-Quiles C; Vaccine Research Department, Fisabio-Public Health, Valencia, Spain.; These authors contributed equally to this article and share first authorship.; CIBERESP, Instituto de Salud Carlos III, Madrid, Spain., Mira-Iglesias A; Vaccine Research Department, Fisabio-Public Health, Valencia, Spain.; CIBERESP, Instituto de Salud Carlos III, Madrid, Spain., López-Labrador FX; CIBERESP, Instituto de Salud Carlos III, Madrid, Spain.; Virology Laboratory, Fisabio-Public Health, Valencia, Spain.; Department of Microbiology and Ecology, Medical School, University of Valencia, Valencia, Spain., Mengual-Chuliá B; CIBERESP, Instituto de Salud Carlos III, Madrid, Spain.; Virology Laboratory, Fisabio-Public Health, Valencia, Spain., Fernández-García C; Vaccine Research Department, Fisabio-Public Health, Valencia, Spain., Carballido-Fernández M; Hospital General Universitario de Castellón, Castellón, Spain.; Medicine Department, Universidad CEU Cardenal Herrera, Castellón de la Plana, Spain., Pineda-Caplliure A; Hospital Universitario Dr. Peset, Valencia, Spain., Mollar-Maseres J; Hospital Universitario La Fe, Valencia, Spain., Shalabi Benavent M; Hospital Marina Baixa, Alicante, Spain., Sanz-Herrero F; Hospital General Universitario, Valencia, Spain., Zornoza-Moreno M; Murcia Health Council, Murcia, Spain., Pérez-Martín JJ; Murcia Health Council, Murcia, Spain., Alfayate-Miguelez S; Murcia Health Council, Murcia, Spain., Pérez Crespo R; Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain., Bastida Sánchez E; Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain., Menasalvas-Ruiz AI; Hospital General Universitario Santa Lucía, Murcia, Spain., Téllez-González MC; Hospital General Universitario Santa Lucía, Murcia, Spain., Esquiva Soto S; Hospital General Universitario Santa Lucía, Murcia, Spain., Del Toro Saravia C; Hospital Rafael Méndez, Murcia, Spain., Sanz-Muñoz I; National Influenza Centre, Valladolid, Spain., Eiros JM; National Influenza Centre, Valladolid, Spain., Matías Del Pozo V; Hospital Clínico, Valladolid, Spain., Toquero-Asensi M; Hospital Clínico, Valladolid, Spain., Pastor-Villalba E; Dirección General de Salud Pública, Valencia, Spain., Lluch-Rodrigo JA; Dirección General de Salud Pública, Valencia, Spain., Díez-Domingo J; Vaccine Research Department, Fisabio-Public Health, Valencia, Spain.; Catholic University of Valencia, Valencia, Spain.; CIBERESP, Instituto de Salud Carlos III, Madrid, Spain., Orrico-Sánchez A; Vaccine Research Department, Fisabio-Public Health, Valencia, Spain.; Catholic University of Valencia, Valencia, Spain.; CIBERESP, Instituto de Salud Carlos III, Madrid, Spain.

Publikováno v: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2024 Feb; Vol. 29 (6).